These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6892233)

  • 1. [Acute effects of nifedipine in hypertrophic cardiomyopathy. Echocardiographic and hemodynamic study].
    Terrosu P; Dore L; Sannia L; Piras L; Ibba GV
    Boll Soc Ital Cardiol; 1981; 26(12):1973-7. PubMed ID: 6892233
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute action of nifedipine in patients with obstructive and nonobstructive asymmetrical septum hypertrophy (ASH)].
    Békés M; Cserhalmi L; Glavanov M; Csukás A; Szilágyi M; Huszár G
    Med Welt; 1980 Sep; 31(39):1408-11. PubMed ID: 6450306
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypertrophic cardiomyopathy with nifedipine and propranolol in combination].
    Hopf R; Thomas J; Klepzig H; Kaltenbach M
    Z Kardiol; 1987 Aug; 76(8):469-78. PubMed ID: 3673167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():105-12. PubMed ID: 3433863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine in hypertrophic cardiomyopathy.
    Pouleur H; Rousseau MF
    Circulation; 1982 Aug; 66(2):478-9. PubMed ID: 7201360
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.
    Lorell BH; Paulus WJ; Grossman W; Wynne J; Cohn PF; Braunwald E
    N Engl J Med; 1980 Oct; 303(14):801-3. PubMed ID: 7191052
    [No Abstract]   [Full Text] [Related]  

  • 8. Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide.
    Pollick C
    N Engl J Med; 1982 Oct; 307(16):997-9. PubMed ID: 7202121
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of nifedipine in association with nitroderivatives and betablocking drugs (author's transl)].
    Aquaro G; Belli R; Rey L; Pavia M; Idone P
    G Ital Cardiol; 1980; 10(10):1340-8. PubMed ID: 7239080
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hemodynamic effects of nifedipine in congestive cardiomyopathy (author's transl)].
    Schiavoni G; Mazzari M; Scabbia E; Coppola E; Domenichelli B; Manzoli U
    G Ital Cardiol; 1980; 10(2):161-6. PubMed ID: 7372031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of hemodynamic parameters after administration of nifedipine in hypertensive patients].
    Varricchio M; Cacciapuoti F; Russo R; Giunta R; Verza M; Grandillo F
    Minerva Cardioangiol; 1980; 28(1-2):59-68. PubMed ID: 7366854
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
    Fedor JM; Stack RS; Pryor DB; Phillips HR
    Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
    Kurita A; Ogawa T; Kanazawa M; Hamamato H; Mabuchi G
    Br J Clin Pract Suppl; 1980; 8():32-6. PubMed ID: 6781515
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of the delayed-action form of korinfar in arterial hypertension, stenocardia and hypertrophic cardiomyopathy].
    Barats SS; Smolenskaia OG; Klets FKh; Zubareva TV; Zakroeva AG; Kots IaI; Tenchurina LR
    Ter Arkh; 1996; 68(1):39-42. PubMed ID: 8644029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
    Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic effects of the calcium antagonist, nifedipine, in acute myocardial infarct].
    Lotto A; Foresti A; Satolli R; Moglia F
    Boll Soc Ital Cardiol; 1978; 23(7):1137-9. PubMed ID: 549608
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic evaluation of nifedipine in hypertensive subjects].
    Bonaduce D; Ferrara N; Petretta M; Romano E; D'Ascia C; Sansone A; Rengo F
    Boll Soc Ital Cardiol; 1980; 25(1):47-53. PubMed ID: 7236428
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic changes caused by nifedipine in ischemic cardiopathy].
    Aquaro G; Idone P; Marra S; Paolillo V; Pavia M
    Boll Soc Ital Cardiol; 1978; 23(8):1365-7. PubMed ID: 549621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.